The health and wellness brand now expects annual underlying earnings to jump by 40% to around £43.3 million after sales soared to £160 million.
Bookmark popover
Coleen Rooney-backed sports health business Applied Nutrition has kicked off its stock market debut with a valuation of around £350 million. (Applied Nutrition/PA) (Applied Nutrition)
Your support helps us to tell the storyRead moreSupport NowFrom reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.Your support makes all the difference.Read more
Applied Nutrition has hiked its earnings outlook thanks to a 50% surge in sales and forecast more growth over the year ahead despite pressure from rising whey prices.
The health and wellness brand – which is backed by TV personality Coleen Rooney – said it now expects annual underlying earnings to jump by 40% to around £43.3 million after sales soared to £160 million in the year to July 31, up from £107 million the previous year.
This compares with previous expectations for earnings of £42 million and revenues of £148.4 million for the full year.
It said that since June 1, trading had remained strong with “sustained demand across the group’s markets and channels”.
Applied Nutrition added it is set for further solid growth in the year to July next year, upping its guidance to £47.7 million in underlying earnings, which would mark a 13% rise, and sales of about £205 million.
RECOMMENDED
Tottenham set to sign another Man City star after Omar Marmoush deal agreed
RSPCA reveals ‘secret weapon’ to tackling common cause of food poisoning
The Richest Person Alive Spends Five Hours a Week on Something Most People Quit in SchoolBlinkist Magazine |
SponsoredSponsored
A Billionaire's Reading List: 5 Books Cuban Says Everyone Should KnowBlinkist Magazine |
SponsoredSponsored
Powered by TaboolaPowered by Taboola
But it cautioned that profitability would be knocked next year as it faces rising costs of whey, which now is used in a greater proportion of products.
The Liverpool-based group recently relaunched its Critical Whey range to tap into rising demand for whey-based products.
It said underlying earnings margins would fall slightly in 2026-27.
Analyst Wayne Brown at Panmure Liberum said: “We upgrade forecasts again, despite the challenges thrown at the industry from higher whey prices, Iran war and a backdrop of low consumer confidence in the UK.
“That said, the long-term trends of health and fitness are clearly global and becoming more entrenched and Applied Nutrition dynamic model is clearly taking significant shelf space as it expands its reach.”
Applied Nutrition’s earnings upgrade comes in spite of the firm cautioning in March that sales volumes would be impacted across the Middle East because of the Iran war.
The group is set to report full-year figures on November 16.